Jeffrey Norton

Publications

• Hospital readmission after a pancreaticoduodenectomy: an emerging quality metric? Kastenberg ZJ, Morton JM, Visser BC, Norton JA, Poultsides GA. HPB (Oxford). 2013; 15 (2): 142-8
• Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine. Park WG, Wu M, Bowen R, Zheng M, Fitch WL, Pai RK, Wodziak D, Visser BC, Poultsides GA, Norton JA, Banerjee S, Chen AM, Friedland S, Scott BA, Pasricha PJ, Lowe AW, Peltz G. Gastrointest Endosc. 2013
• Preexisting antitumor immunity augments the antitumor effects of chemotherapy. Zhang L, Feng D, Yu LX, Tsung K, Norton JA. Cancer Immunol Immunother. 2013; 62 (6): 1061-71
• Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: is there room for improvement? Patel MI, Rhoads KF, Ma Y, Ford JM, Visser BC, Kunz PL, Fisher GA, Chang DT, Koong A, Norton JA, Poultsides GA. Ann Surg Oncol. 2013; 20 (5): 1631-8
• Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes. Visser BC, Ma Y, Zak Y, Poultsides GA, Norton JA, Rhoads KF. HPB (Oxford). 2012; 14 (8): 539-47
• Intensity-modulated radiotherapy for pancreatic adenocarcinoma. Abelson JA, Murphy JD, Minn AY, Chung M, Fisher GA, Ford JM, Kunz P, Norton JA, Visser BC, Poultsides GA, Koong AC, Chang DT. Int J Radiat Oncol Biol Phys. 2012; 82 (4): e595-601
• Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis. Poultsides GA, Huang LC, Chen Y, Visser BC, Pai RK, Jeffrey RB, Park WG, Chen AM, Kunz PL, Fisher GA, Norton JA. Ann Surg Oncol. 2012; 19 (7): 2295-303
• Recurrent duodenal stricture secondary to untreated Crohn's disease. Plerhoples TA, Norton JA. Dig Dis Sci. 2012; 57 (10): 2516-8
• Value of surgery in patients with negative imaging and sporadic Zollinger-Ellison syndrome. Norton JA, Fraker DL, Alexander HR, Jensen RT. Ann Surg. 2012; 256 (3): 509-17
• A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer. Chen Y, Kingham K, Ford JM, Rosing J, Van Dam J, Jeffrey RB, Longacre TA, Chun N, Kurian A, Norton JA. Ann Surg Oncol. 2011; 18 (9): 2594-8
• Pancreatic endocrine tumors with major vascular abutment, involvement, or encasement and indication for resection. Norton JA, Harris EJ, Chen Y, Visser BC, Poultsides GA, Kunz PC, Fisher GA, Jensen RT. Arch Surg. 2011; 146 (6): 724-32
• Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease. Pai RK, Beck AH, Mitchem J, Linehan DC, Chang DT, Norton JA, Pai RK. Am J Surg Pathol. 2011; 35 (2): 228-34
• Ruptured biliary cystadenoma managed by angiographic embolization and interval partial hepatectomy. Ghole SA, Bakhtary S, Staudenmayer K, Sze DY, Pai RK, Visser BC, Norton JA, Poultsides GA. Dig Dis Sci. 2011; 56 (7): 1949-53
• Supercharged jejunum flap for total esophageal reconstruction: single-surgeon 3-year experience and outcomes analysis. Barzin A, Norton JA, Whyte R, Lee GK. Plast Reconstr Surg. 2011; 127 (1): 173-80
• Surgical management of neuroendocrine tumors of the gastrointestinal tract. Huang LC, Poultsides GA, Norton JA. Oncology (Williston Park). 2011; 25 (9): 794-803
• Total gastrectomy and identified CDH1 mutations: in response. Norton JA, Chen Y. Ann Surg Oncol. 2011: 18 Suppl 3 208
• A novel PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease and the Carney complex. Peck MC, Visser BC, Norton JA, Pasche L, Katznelson L. Endocr Pract. 2010 Mar-Apr; 16 (2): 198-204
• Comparison of intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer. Minn AY, Hsu A, La T, Kunz P, Fisher GA, Ford JM, Norton JA, Visser B, Goodman KA, Koong AC, Chang DT. Cancer. 2010; 116 (16): 3943-52
• Expression of p16(INK4A) but not hypoxia markers or poly adenosine diphosphate-ribose polymerase is associated with improved survival in patients with pancreatic adenocarcinoma. Chang DT, Chapman CH, Norton JA, Visser B, Fisher GA, Kunz P, Ford JM, Koong AC, Pai RK. Cancer. 2010; 116 (22): 5179-87
• Interfractional uncertainty in the treatment of pancreatic cancer with radiation. Jayachandran P, Minn AY, Van Dam J, Norton JA, Koong AC, Chang DT. Int J Radiat Oncol Biol Phys. 2010; 76 (2): 603-7
• Role of factor VII in correcting dilutional coagulopathy and reducing re-operations for bleeding following non-traumatic major gastrointestinal and abdominal surgery. Tsai TC, Rosing JH, Norton JA. J Gastrointest Surg. 2010; 14 (8): 1311-8
• Solid pseudopapillary tumor of the pancreas: an unexpected finding after minor abdominal trauma. Cisco R, Jeffrey RB, Norton JA. Dig Dis Sci. 2010; 55 (2): 240-1
• Appendiceal mucinous neoplasms: clinicopathologic study of 116 cases with analysis of factors predicting recurrence. Pai RK, Beck AH, Norton JA, Longacre TA. Am J Surg Pathol. 2009; 33 (10): 1425-39
• Major blood vessel reconstruction during sarcoma surgery. Song TK, Harris EJ, Raghavan S, Norton JA. Arch Surg. 2009; 144 (9): 817-22
• Surgical management of Zollinger-Ellison syndrome; state of the art. Morrow EH, Norton JA. Surg Clin North Am. 2009; 89 (5): 1091-103
• The value of surgery for retroperitoneal sarcoma. Gholami S, Jacobs CD, Kapp DS, Parast LM, Norton JA. Sarcoma. 2009: 2009 605840
• Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. Schellenberg D, Goodman KA, Lee F, Chang S, Kuo T, Ford JM, Fisher GA, Quon A, Desser TS, Norton J, Greco R, Yang GP, Koong AC. Int J Radiat Oncol Biol Phys. 2008; 72 (3): 678-86
• Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery. Cisco RM, Ford JM, Norton JA. Cancer. 2008; 113 (7 Suppl): 1850-6
• Hereditary diffuse gastric cancer: surgery, surveillance and unanswered questions. Cisco RM, Norton JA. Future Oncol. 2008; 4 (4): 553-9
• Identifying and Preventing High-risk Gastric Cancer Individuals With CDH1 Mutations. Norton JA, Ford JM. Ann Surg. 2008; 247 (4): 715-716
• Identifying and Preventing High-risk Gastric Cancer Individuals With CDH1 Mutations. Norton JA, Ford JM. Ann Surg. 2008; 247 (4): 715-6
• Intraoperative radiation therapy for locally advanced and recurrent soft-tissue sarcomas in adults. Tran PT, Hara W, Su Z, Lin HJ, Bendapudi PK, Norton J, Teng N, King CR, Kapp DS. Int J Radiat Oncol Biol Phys. 2008; 72 (4): 1146-53
• Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT. Norton JA, Venzon DJ, Berna MJ, Alexander HR, Fraker DL, Libutti SK, Marx SJ, Gibril F, Jensen RT. Ann Surg. 2008; 247 (3): 501-10
• Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications. Rogers WM, Dobo E, Norton JA, Van Dam J, Jeffrey RB, Huntsman DG, Kingham K, Chun N, Ford JM, Longacre TA. Am J Surg Pathol. 2008; 32 (6): 799-809
• Tissue effects after stereotactic body radiotherapy using cyberknife for patients with abdominal malignancies. Cupp JS, Koong AC, Fisher GA, Norton JA, Goodman KA. Clin Oncol (R Coll Radiol). 2008; 20 (1): 69-75
• CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Norton JA, Ham CM, Van Dam J, Jeffrey RB, Longacre TA, Huntsman DG, Chun N, Kurian AW, Ford JM. Ann Surg. 2007; 245 (6): 873-9
• Role of surgery in Zollinger-Ellison syndrome. Norton JA, Jensen RT. J Am Coll Surg. 2007; 205 (4 Suppl): S34-7
• Surgery for gastrinoma. Cisco RM, Norton JA. Adv Surg. 2007: 41 165-76
• Inhibition of host signal transducer and activator of transcription factor 6 results in cure with cyclophosphamide and interleukin 12 immunotherapy. Norton JA, Li M, Lee NC, Tsung K. Ann Surg Oncol. 2006; 13 (1): 118-24
• Lessons from Coley's Toxin. Tsung K, Norton JA. Surg Oncol. 2006; 15 (1): 25-8
• Surgery for gastrinoma and insulinoma in multiple endocrine neoplasia type 1. Norton JA, Fang TD, Jensen RT. J Natl Compr Canc Netw. 2006; 4 (2): 148-53
• Surgery for primary pancreatic neuroendocrine tumors. Norton JA, J Gastrointest Surg. 2006; 10 (3): 327-31
• Surgery increases survival in patients with gastrinoma. Norton JA, Fraker DL, Alexander HR, Gibril F, Liewehr DJ, Venzon DJ, Jensen RT. Ann Surg. 2006; 244 (3): 410-9
• A national comparison of surgical versus percutaneous drainage of pancreatic pseudocysts: 1997-2001. Morton JM, Brown A, Galanko JA, Norton JA, Grimm IS, Behrns KE. J Gastrointest Surg. 2005; 9 (1): 15-20; discussion 20-1
• Computed tomography, endoscopic, laparoscopic, and intra-operative sonography for assessing resectability of pancreatic cancer. Long EE, Van Dam J, Weinstein S, Jeffrey B, Desser T, Norton JA. Surg Oncol. 2005; 14 (2): 105-13
• Endocrine tumours of the gastrointestinal tract. Surgical treatment of neuroendocrine metastases. Norton JA, Best Pract Res Clin Gastroenterol. 2005; 19 (4): 577-83
• Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Koong AC, Christofferson E, Le QT, Goodman KA, Ho A, Kuo T, Ford JM, Fisher GA, Greco R, Norton J, Yang GP. Int J Radiat Oncol Biol Phys. 2005; 63 (2): 320-3
• Surgery and prognosis of duodenal gastrinoma as a duodenal neuroendocrine tumor. Norton JA, Best Pract Res Clin Gastroenterol. 2005; 19 (5): 699-704
• Surgical treatment and prognosis of gastrinoma. Norton JA, Best Pract Res Clin Gastroenterol. 2005; 19 (5): 799-805
• Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases, or survival in patients with Zollinger-Ellison syndrome? Norton JA, Alexander HR, Fraker DL, Venzon DJ, Gibril F, Jensen RT. Ann Surg. 2004; 239 (5): 617-25; discussion 626
• Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment. Norton JA, Melcher ML, Gibril F, Jensen RT. Surgery. 2004; 136 (6): 1267-74
• Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome. Norton JA, Jensen RT. Ann Surg. 2004; 240 (5): 757-73
• A high-resolution radiation hybrid map of the human genome draft sequence. Olivier M, Aggarwal A, Allen J, Almendras AA, Bajorek ES, Beasley EM, Brady SD, Bushard JM, Bustos VI, Chu A, Chung TR, De Witte A, Denys ME, Dominguez R, Fang NY, Foster BD, Freudenberg RW, Hadley D, Hamilton LR, Jeffrey TJ, Kelly L, Lazzeroni L, Levy MR, Lewis SC, Liu X, Lopez FJ, Louie B, Marquis JP, Martinez RA, Matsuura MK, Misherghi NS, Norton JA, Olshen A, Perkins SM, Perou AJ, Piercy C, Piercy M, Qin F, Reif T, Sheppard K, Shokoohi V, Smick GA, Sun WL, Stewart EA, Fernando J, Tejeda, Tran NM, Trejo T, Vo NT, Yan SC, Zierten DL, Zhao S, Sachidanandam R, Trask BJ, Myers RM, Cox DR. Science. 2001; 291 (5507): 1298-302